ANS abre Consulta Pública para avaliar incorporação de terapia para linfoma de células do manto na rede privada
07.08.2025 - 18:02:56
Acessado em 23 de maio de 2023
4 Hess LM, et al. Outcomes among Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States: A Real-World Electronic Medical Records Study. Adv Hematol. 2022 Dec 28;2022
5 McCulloch R, et al. Br J Haematol. 2020;189(4):684-688. 2. Cheah CY, et al. Ann Oncol. 2015;26(6):1175-1179
4 Hess LM, et al. Outcomes among Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States: A Real-World Electronic Medical Records Study. Adv Hematol. 2022 Dec 28;2022
5 McCulloch R, et al. Br J Haematol. 2020;189(4):684-688. 2. Cheah CY, et al. Ann Oncol. 2015;26(6):1175-1179
PP-PT-BR-0202 – MARÇO 2025
View original content:https://www.prnewswire.com/br/comunicados-para-a-imprensa/ans-abre-consulta-publica-para-avaliar-incorporacao-de-terapia-para-linfoma-de-celulas-do-manto-na-rede-privada-302424801.html
FONTE Eli Lilly do Brasil
